This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Torten, M Articles by Pedersen, N C Search for Related Content PubMed PubMed Citation Articles by Torten, M Articles by Pedersen, N C

 Previous Article  |  Next Article 

J Virol. 1991 May; 65(5): 2225-2230

Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus.

Department of Medicine, School of Veterinary Medicine, University of California, Davis 95616.

ABSTRACT

Within 6 months of infection with the Petaluma isolate of feline immunodeficiency virus, specific-pathogen-free domestic cats exhibited a decrease in the percentage and number of circulating CD4+ lymphocytes and in the CD4+/CD8+ T-cell ratio, along with a marginally significant depression of pokeweed mitogen-induced lymphocyte proliferation in vitro. There was no loss of responsiveness to concanavalin A during this stage, and the cats were capable of mounting a satisfactory antibody response to a T-dependent, synthetic polypeptide immunogen. The pokeweed mitogen response deficit became clearly demonstrable by 11 to 12 months postinfection. A decline in the lymphocyte proliferative response to concanavalin A and a diminished ability to mount an in vivo antibody response to the T-dependent immunogen evolved by 25 to 44 months postinfection. Virus infection did not affect the ability of cats to mount an antibody response to a T-independent synthetic polypeptide immunogen. These data indicate that feline immunodeficiency virus produces a slowly progressive deterioration of T-cell function but does not affect the ability of B cells to recognize and respond to a T-independent antigenic stimulus.

This article has been cited by other articles:

• de Parseval, A., Chatterji, U., Sun, P., Elder, J. H. (2004). Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. USA 101: 13044-13049 [Abstract] [Full Text]  
• Stevens, R., Howard, K. E., Nordone, S., Burkhard, M., Dean, G. A. (2004). Oral Immunization with Recombinant Listeria monocytogenes Controls Virus Load after Vaginal Challenge with Feline Immunodeficiency Virus. J. Virol. 78: 8210-8218 [Abstract] [Full Text]  
• Vahlenkamp, T. W., Tompkins, M. B., Tompkins, W. A. F. (2004). Feline Immunodeficiency Virus Infection Phenotypically and Functionally Activates Immunosuppressive CD4+CD25+ T Regulatory Cells. J. Immunol. 172: 4752-4761 [Abstract] [Full Text]  
• Gemeniano, M. C., Sawai, E. T., Leutenegger, C. M., Sparger, E. E. (2003). Feline Immunodeficiency Virus Orf-A Is Required for Virus Particle Formation and Virus Infectivity. J. Virol. 77: 8819-8830 [Abstract] [Full Text]  
• Willett, B. J., Cannon, C. A., Hosie, M. J. (2002). Upregulation of Surface Feline CXCR4 Expression following Ectopic Expression of CCR5: Implications for Studies of the Cell Tropism of Feline Immunodeficiency Virus. J. Virol. 76: 9242-9252 [Abstract] [Full Text]  
• Hosie, M. J., Willett, B. J., Klein, D., Dunsford, T. H., Cannon, C., Shimojima, M., Neil, J. C., Jarrett, O. (2002). Evolution of Replication Efficiency following Infection with a Molecularly Cloned Feline Immunodeficiency Virus of Low Virulence. J. Virol. 76: 6062-6072 [Abstract] [Full Text]  
• Hayes, K. A., Phipps, A. J., Francke, S., Mathes, L. E. (2000). Antiviral Therapy Reduces Viral Burden but Does Not Prevent Thymic Involution in Young Cats Infected with Feline Immunodeficiency Virus. Antimicrob. Agents Chemother. 44: 2399-2405 [Abstract] [Full Text]  
• Dean, G. A., Himathongkham, S., Sparger, E. E. (1999). Differential Cell Tropism of Feline Immunodeficiency Virus Molecular Clones In Vivo. J. Virol. 73: 2596-2603 [Abstract] [Full Text]